Skip to main content

Arcutis Biotherapeutics, Inc.

ARQT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001787306

In the last 90 days, Arcutis Biotherapeutics, Inc. insiders filed 0 open-market purchases and 12 sales; 272 institutions reported holding it in 13F filings for Q2 2026, worth $3.45B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Arcutis Biotherapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
12 filings
5 insiders, $2.30M in total
Insiders trading
5
Net value
−$2.30M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Arcutis Biotherapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Arcutis Biotherapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Matsuda MasaruSee Remarks112,508Sep 18, 20269
Welgus Howard G.Director35,841Sep 17, 202613
Curran TerrieDirector23,526Aug 28, 20263
Burnett PatrickSee Remarks117,592Aug 21, 202612
Watanabe Todd FranklinSee Remarks717,203Aug 5, 20268
Peetz ChristopherDirector4,315Jul 17, 20261
Lin Sue-JeanDirector27,567Jun 17, 20263
Heron Patrick JDirector32,213Jun 12, 20261
Leonard Keith RDirector27,901Jun 9, 20263
Gilbert Halley EDirector27,901Jun 9, 20262
Munshi AmitDirector9,799Jun 9, 20262
Krishnamohan NehaDirector27,901Jun 9, 20262
Vairavan LathaSVP Chief Financial Officer85,978May 13, 20265
Edwards Larry ToddSee Remarks175,178Mar 3, 20264
Chaudhuri BhaskarDirector867,826Jun 16, 20250
Topper David JosephChief Financial Officer182,774Apr 3, 20250
Moore Matthew RichardSVP and Chief Business Officer145,505May 3, 20240
Smither John WChief Financial Officer11,365Feb 15, 20240
Topper James N10% Owner8,764,232Oct 26, 20230
Frazier Life Sciences VIII, L.P.10% Owner8,764,232Oct 26, 20230
FHM Life Sciences VIII, L.P.10% Owner8,764,232Oct 26, 20230
FHM Life Sciences VIII, L.L.C.10% Owner8,764,232Oct 26, 20230
Osborne David WChief Technical Officer268,854Mar 8, 20230
Turney Patricia A.SVP, Operations62,862Mar 8, 20230
Lock Kenneth A.Chief Commercial Officer63,429Mar 8, 20230
Burrows Scott LChief Financial Officer59,115Mar 8, 20230
OrbiMed Advisors LLC10% Owner415,142IndirectJun 28, 20220
OrbiMed Capital LLC10% Owner415,142IndirectJun 28, 20220
OrbiMed Capital GP VII LLC10% Owner415,142IndirectJun 28, 20220
Turner Joseph LDirector4,312Jun 3, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 3, 2024 (view filing)Nov 303 daysEdwards Larry ToddSee RemarksPPurchase+1.09K$7.11+$7.77K+0.8%137.7K after
Dec 3, 2024 (view filing)May 31-Nov 30186 daysLateMatsuda MasaruSee RemarksPPurchase+5.66K$3.28+$18.5K+3.1%187.0K after2 lots
Dec 3, 2024 (view filing)Dec 21 dayWelgus Howard G.DirectorSSale−10.0K$12.51−$125.1K−5.8%161.9K after10b5-1
Dec 3, 2024 (view filing)May 31-Nov 30186 daysLateWatanabe Todd FranklinSee RemarksPPurchase+6.04K$3.52+$21.3K+0.7%838.4K after2 lots
Nov 26, 2024 (view filing)Nov 224 daysBurnett PatrickSee RemarksSSale−16.0K$10.14−$162.5K−11.1%128.7K after
Nov 19, 2024 (view filing)Nov 19Same dayMatsuda MasaruSee RemarksSSale−1.77K$9.68−$17.2K−1.0%181.4K after10b5-1
Nov 18, 2024 (view filing)Nov 14-154 daysBurnett PatrickSee RemarksSSale−69.2K$10.29−$712.3K−35.0%128.7K after3 lots
Nov 13, 2024 (view filing)Nov 112 daysCurran TerrieDirectorSSale−8.69K$10.85−$94.3K−46.1%10.1K after
Nov 5, 2024 (view filing)Nov 41 dayMatsuda MasaruSee RemarksSSale−5.01K$8.68−$43.5K−2.7%178.3K after10b5-1
Nov 5, 2024 (view filing)Nov 41 dayWatanabe Todd FranklinSee RemarksSSale−13.9K$8.68−$120.4K−1.6%832.4K after10b5-1
Nov 5, 2024 (view filing)Nov 14 daysWelgus Howard G.DirectorSSale−10.0K$8.65−$86.5K−5.5%171.9K after10b5-1
Nov 5, 2024 (view filing)Nov 41 dayBurnett PatrickSee RemarksSSale−15.4K$8.68−$134.0K−7.9%179.4K after10b5-1
Oct 3, 2024 (view filing)Oct 12 daysWelgus Howard G.DirectorSSale−10.0K$9.26−$92.6K−5.2%181.9K after10b5-1
Oct 3, 2024 (view filing)Oct 21 dayEdwards Larry ToddSVP Chief Commercial OfficerSSale−3.73K$10.01−$37.3K−2.7%136.6K after10b5-1
Sep 25, 2024 (view filing)Sep 241 dayTopper David JosephChief Financial OfficerSSale−11.6K$9.48−$110.2K−6.8%158.4K after
Sep 5, 2024 (view filing)Sep 32 daysWelgus Howard G.DirectorSSale−10.0K$10.77−$107.7K−5.0%191.9K after10b5-1
Aug 21, 2024 (view filing)Aug 192 daysBurnett PatrickSee RemarksSSale−1.73K$8.29−$14.3K−0.9%194.9K after10b5-1
Aug 5, 2024 (view filing)Aug 23 daysMatsuda MasaruSee RemarksSSale−5.22K$9.02−$47.1K−2.8%183.3K after10b5-1
Aug 5, 2024 (view filing)Aug 23 daysBurnett PatrickSee RemarksSSale−13.2K$9.02−$119.1K−6.3%196.6K after10b5-1
Aug 5, 2024 (view filing)Aug 23 daysWatanabe Todd FranklinSee RemarksSSale−14.5K$9.02−$130.7K−1.7%846.3K after10b5-1
Aug 5, 2024 (view filing)Aug 14 daysWelgus Howard G.DirectorSSale−10.0K$9.87−$98.7K−5.3%177.0K after2 lots10b5-1
Jul 2, 2024 (view filing)Jul 11 dayWelgus Howard G.DirectorSSale−10.0K$9.31−$93.1K−5.3%180.3K after10b5-1
Jun 6, 2024 (view filing)Jun 42 daysWelgus Howard G.DirectorSSale−10.0K$8.01−$80.1K−5.5%170.2K after2 lots
May 31, 2024 (view filing)May 29-302 daysBurnett PatrickSee RemarksSSale−73.0K$8.73−$636.8K−25.8%209.8K after2 lots
May 29, 2024 (view filing)May 281 dayMatsuda MasaruSee RemarkSSale−1.77K$9.01−$16.0K−0.9%188.5K after10b5-1
May 20, 2024 (view filing)May 173 daysEdwards Larry ToddSVP Chief Commercial OfficerSSale−7.64K$8.98−$68.6K−5.2%140.4K after
May 3, 2024 (view filing)May 21 dayMoore Matthew RichardSVP and Chief Business OfficerSSale−4.68K$8.74−$40.9K−3.1%145.5K after10b5-1
May 3, 2024 (view filing)May 21 dayWatanabe Todd FranklinSee RemarksSSale−13.8K$8.74−$120.5K−1.6%860.8K after10b5-1
May 3, 2024 (view filing)May 21 dayMatsuda MasaruSee RemarkSSale−5.02K$8.74−$43.8K−2.6%185.4K after10b5-1
May 3, 2024 (view filing)May 21 dayBurnett PatrickSee RemarksSSale−9.55K$8.74−$83.5K−3.5%259.7K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysMatsuda MasaruSee RemarkSSale−3.76K$11.12−$41.8K−1.9%190.4K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysBurnett PatrickSee RemarksSSale−4.78K$11.12−$53.2K−1.7%269.3K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysWatanabe Todd FranklinSee RemarksSSale−14.9K$11.12−$165.7K−1.7%874.5K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysMoore Matthew RichardSVP and Chief Business OfficerSSale−3.47K$11.12−$38.6K−2.3%146.0K after10b5-1
Mar 6, 2024 (view filing)Mar 42 daysHeron Patrick JDirectorPPurchase+21.1K$9.50+$200.0K+0.2%8.79M after
Mar 1, 2024 (view filing)Feb 282 daysWatanabe Todd FranklinSee RemarksSSale−2.46K$10.60−$26.1K−0.3%889.4K after10b5-1
Jan 3, 2024 (view filing)Jan 21 dayBurnett PatrickSee RemarksSSale−1.32K$3.54−$4.69K−2.3%57.0K after
Dec 1, 2023 (view filing)May 31184 daysLateWatanabe Todd FranklinSee RemarksPPurchase+1.46K$6.38+$9.33K+0.3%515.1K after
Nov 21, 2023 (view filing)Nov 21Same dayMatsuda MasaruSee RemarkSSale−1.85K$1.98−$3.66K−3.8%46.6K after
Oct 26, 2023 (view filing)4:09 PM ETOct 242 daysHeron Patrick J and 4 othersDirector, 10% OwnerPPurchase+80.0K$2.50+$200.0K+0.9%8.76M after
Aug 22, 2023 (view filing)Aug 211 dayBurnett PatrickSee RemarksSSale−1.60K$7.04−$11.3K−2.7%58.4K after2 lots
Jun 2, 2023 (view filing)May 312 daysMatsuda MasaruSee RemarkSSale−1.83K$7.80−$14.3K−4.2%42.1K after
Apr 18, 2023 (view filing)Apr 171 dayWelgus Howard G.DirectorSSale−8.50K$13.97−$118.7K−4.9%165.8K after10b5-1
Apr 10, 2023 (view filing)Apr 64 daysWelgus Howard G.DirectorSSale−8.50K$12.01−$102.1K−4.9%165.8K after10b5-1
Mar 8, 2023 (view filing)Mar 62 daysWatanabe Todd FranklinSee RemarksSSale−2.44K$15.26−$37.2K−0.7%366.7K after
Mar 8, 2023 (view filing)Mar 62 daysBurrows Scott LChief Financial OfficerSSale−291$15.26−$4.44K−0.5%59.1K after
Mar 8, 2023 (view filing)Mar 62 daysBurnett PatrickSee RemarksSSale−851$15.26−$13.0K−1.4%60.0K after
Mar 8, 2023 (view filing)Mar 62 daysTurney Patricia A.SVP, OperationsSSale−831$15.26−$12.7K−1.3%62.9K after
Mar 8, 2023 (view filing)Mar 62 daysOsborne David WChief Technical OfficerSSale−690$15.26−$10.5K−0.3%268.9K after
Mar 8, 2023 (view filing)Mar 62 daysLock Kenneth A.Chief Commercial OfficerSSale−831$15.26−$12.7K−1.3%63.4K after